한글목차

면역조절제 동향 및 전망

세계 면역조절제 시장은 2024년부터 2030년까지 4.6%의 연평균 복합 성장률(CAGR)로 2030년까지 약 2억 9,800만 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 다발성 경화증 유병률 증가, 효율적인 약물에 대한 환자의 요구 증가, 자가 면역 질환의 비율 증가입니다. 세계 면역조절제 시장의 미래는 호흡기, 종양 및 HIV 시장의 기회로 인해 유망한 것으로 보입니다.

부문별 면역조절제

이 보고서는 세계 면역조절제의 제품 유형별, 용도별, 지역별 예측을 담고 있습니다.

면역조절제 시장 인사이트

Lucintel의 예측에 따르면, 면역억제제는 많은 자가면역질환을 치료하기 때문에 예측 기간 동안 높은 성장세를 보일 것으로 예상됩니다.

이 시장 중 암 분야는 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.

북미는 인구의 만성질환 유병률 증가와 주요 기업들의 진출로 인해 예측 기간 동안 가장 규모가 큰 지역으로 남을 것입니다.

자주 묻는 질문

Q1. 시장 규모 :

A1. 세계 면역조절제 시장은 2030년까지 약 2억 9,800만 달러에 달할 것으로 예상됩니다.

Q2. 시장 성장 예측은 다음과 같습니다.

A2. 세계 면역조절제 시장은 2024년부터 2030년까지 연평균 4.6%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

Q3. 시장 성장에 영향을 미치는 주요 촉진요인은 다음과 같습니다.

A3.이 시장의 주요 촉진요인은 다발성 경화증 발병률 증가, 효율적인 약물에 대한 환자의 요구 증가, 자가 면역 질환의 비율 증가입니다.

Q4. 시장의 주요 부문은 다음과 같습니다.

A4. 면역조절제 시장의 미래는 호흡기, 종양, HIV 시장에 기회가 있고 유망합니다.

Q5. 시장 주요 기업은 다음과 같습니다.

A5. 주요 면역조절제 기업은 다음과 같습니다.

• F. Hoffmann-La Roche
• Novartis
• Biogen
• Teva Pharmaceutical Industries
• Amgen
• Bristol-Myers & Squibb Company
• Merck Sharp & Dohme

Q6. 향후 가장 큰 시장 부문은 다음과 같습니다.

A6. Lucintel의 예측에 따르면, 면역억제제는 자가면역질환을 치료할 수 있는 능력으로 인해 예측 기간 동안 높은 성장세를 보일 것으로 예상됩니다.

Q7. 시장에서 향후 5년간 가장 큰 시장이 될 것으로 예상되는 지역은 어디입니까?

A7. 북미는 인구의 만성질환 유병률 증가와 주요 기업들의 진출로 인해 예측 기간 동안 가장 규모가 큰 지역으로 남을 것으로 예상됩니다.

Q8. 보고서 사용자 정의가 가능합니까?

A8. 네. Lucintel은 추가 비용없이 10%의 사용자 정의를 제공합니다.

목차

제1장 주요 요약

제2장 세계의 면역조절제 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 시장 동향과 예측 분석(2018-2030년)

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 면역조절제 시장 동향(2018-2023년)과 예측(2024-2030년)
• 제품 유형별 세계의 면역조절제 시장
  • 면역 억제제
  • 면역 자극제
• 용도별 세계의 면역조절제 시장
  • 호흡기
  • 종양
  • HIV
  • 기타

제4장 지역별 시장 동향과 예측 분석(2018-2023년)

• 지역별 세계의 면역조절제 시장
• 북미의 면역조절제 시장
• 유럽의 면역조절제 시장
• 아시아태평양의 면역조절제 시장
• 기타 지역의 면역조절제 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 업무 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
• 세계 면역조절제 시장의 새로운 동향
• 전략 분석
  • 신제품 개발
  • 세계의 면역조절제 시장 생산능력 확대
  • 세계 면역조절제 시장에서의 인수합병(M&A) 및 합작투자(JV)
  • 인증과 라이선싱

제7장 주요 기업 개요

• F. Hoffmann-La Roche
• Novartis
• Biogen
• Teva Pharmaceutical Industries
• Amgen
• Bristol-Myers & Squibb Company
• Merck Sharp & Dohme

영문목차

Immunomodulator Trends and Forecast

The future of the global immunomodulator market looks promising with opportunities in the respiratory, oncology, and HIV markets. The global immunomodulator market is expected to reach an estimated $298.0 million by 2030 with a CAGR of 4.6% from 2024 to 2030. The major drivers for this market are increasing multiple sclerosis incidence, rising patient need for efficient medications, and growing rates of autoimmune disorders.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Immunomodulator by Segment

The study includes a forecast for the global immunomodulator by product type, application, and region.

Immunomodulator Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Immunosuppressants
• Immunostimulants

Immunomodulator Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Respiratory
• Oncology
• HIV
• Others

Immunomodulator Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Immunomodulator Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies immunomodulator companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the immunomodulator companies profiled in this report include-

• F. Hoffmann-La Roche
• Novartis
• Biogen
• Teva Pharmaceutical Industries
• Amgen
• Bristol-Myers & Squibb Company
• Merck Sharp & Dohme

Immunomodulator Market Insights

Lucintel forecasts that immunosuppressant is expected to witness higher growth over the forecast period due to their ability to cure a number of autoimmune illnesses.

Within this market, oncology is expected to witness the highest growth over the forecast period.

North America will remain the largest region over the forecast period due to increasing prevalence of chronic diseases among population and presence of key players in the region.

Features of the Global Immunomodulator Market

Market Size Estimates: Immunomodulator market size estimation in terms of value ($M).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Immunomodulator market size by product type, application, and region in terms of value ($M).

Regional Analysis: Immunomodulator market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, applications, and regions for the immunomodulator market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the immunomodulator market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the immunomodulator market size?

Answer: The global immunomodulator market is expected to reach an estimated $298.0 million by 2030.

Q2. What is the growth forecast for immunomodulator market?

Answer: The global immunomodulator market is expected to grow with a CAGR of 4.6% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the immunomodulator market?

Answer: The major drivers for this market are increasing multiple sclerosis incidence, rising patient need for efficient medications, and growing rates of autoimmune disorders.

Q4. What are the major segments for immunomodulator market?

Answer: The future of the immunomodulator market looks promising with opportunities in the respiratory, oncology, and HIV markets.

Q5. Who are the key immunomodulator market companies?

Answer: Some of the key immunomodulator companies are as follows:

• F. Hoffmann-La Roche
• Novartis
• Biogen
• Teva Pharmaceutical Industries
• Amgen
• Bristol-Myers & Squibb Company
• Merck Sharp & Dohme

Q6. Which immunomodulator market segment will be the largest in future?

Answer: Lucintel forecasts that immunosuppressant is expected to witness higher growth over the forecast period due to their ability to cure a number of autoimmune illnesses.

Q7. In immunomodulator market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing prevalence of chronic diseases among population and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the immunomodulator market by product type (immunosuppressants and immunostimulants), application (respiratory, oncology, HIV, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Immunomodulator Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Immunomodulator Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Immunomodulator Market by Product Type
  • 3.3.1: Immunosuppressants
  • 3.3.2: Immunostimulants
• 3.4: Global Immunomodulator Market by Application
  • 3.4.1: Respiratory
  • 3.4.2: Oncology
  • 3.4.3: HIV
  • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Immunomodulator Market by Region
• 4.2: North American Immunomodulator Market
  • 4.2.1: North American Immunomodulator Market by Product Type: Immunosuppressants and Immunostimulants
  • 4.2.2: North American Immunomodulator Market by Application: Respiratory, Oncology, HIV, and Others
• 4.3: European Immunomodulator Market
  • 4.3.1: European Immunomodulator Market by Product Type: Immunosuppressants and Immunostimulants
  • 4.3.2: European Immunomodulator Market by Application: Respiratory, Oncology, HIV, and Others
• 4.4: APAC Immunomodulator Market
  • 4.4.1: APAC Immunomodulator Market by Product Type: Immunosuppressants and Immunostimulants
  • 4.4.2: APAC Immunomodulator Market by Application: Respiratory, Oncology, HIV, and Others
• 4.5: ROW Immunomodulator Market
  • 4.5.1: ROW Immunomodulator Market by Product Type: Immunosuppressants and Immunostimulants
  • 4.5.2: ROW Immunomodulator Market by Application: Respiratory, Oncology, HIV, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Immunomodulator Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Immunomodulator Market by Application
  • 6.1.3: Growth Opportunities for the Global Immunomodulator Market by Region
• 6.2: Emerging Trends in the Global Immunomodulator Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Immunomodulator Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Immunomodulator Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: F. Hoffmann-La Roche
• 7.2: Novartis
• 7.3: Biogen
• 7.4: Teva Pharmaceutical Industries
• 7.5: Amgen
• 7.6: Bristol-Myers & Squibb Company
• 7.7: Merck Sharp & Dohme